The historical rank and industry rank for Apures Co's EV-to-EBIT or its related term are showing as below:
XKRX:149300'
s EV-to-EBIT Range Over the Past 10 Years
Min: -42.54 Med: -7.89 Max: -3.99
Current: -4.82
During the past 10 years, the highest EV-to-EBIT of Apures Co was -3.99. The lowest was -42.54. And the median was -7.89.
XKRX:149300's EV-to-EBIT is ranked worse than 100% of 103
companies
in the Medical Diagnostics & Research industry
Industry Median: 21.9
vs XKRX:149300: -4.82
The historical data trend for Apures Co's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Apures Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Apures Co's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Apures Co's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Apures Co's EV-to-EBIT falls into.
Apures Co EV-to-EBIT Calculation
Apures Co's EV-to-EBIT for today is calculated as:
Apures Co's current Enterprise Value is ₩22,613.0 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Apures Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-4,694.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Apures Co (XKRX:149300) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Apures Co's Enterprise Value for the quarter that ended in Dec. 2023 was ₩24,787.3 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Apures Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-4,694.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Apures Co EV-to-EBIT Related Terms
Thank you for viewing the detailed overview of Apures Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
Apures Co Ltd is a South Korea based company engaged in the development of transgenic animals to support bio heterogeneous long-term commercialization and new drug efficacy research. It has focused its research capabilities on developing transgenic mini pigs based on gene editing technology and somatic cell nuclear transfer technology.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XKRX:149300 has been successfully added to your 